These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 3675730)
1. On the mode of action of six putative dopamine receptor agonists on suppression of exploratory behaviour in rats. Ståhle L; Ungerstedt U Psychopharmacology (Berl); 1987; 91(2):139-46. PubMed ID: 3675730 [TBL] [Abstract][Full Text] [Related]
2. Yawning and suppression of exploration in amphetamine-treated rats, incompatibility with the autoreceptor hypothesis. Ståhle L; Ungerstedt U Psychopharmacology (Berl); 1989; 97(4):553-60. PubMed ID: 2567032 [TBL] [Abstract][Full Text] [Related]
3. Relative selectivity of 6,7-dihydroxy-2-dimethylaminotetralin, N-n-propyl-3-(3-hydroxyphenyl)piperidine, N-n-propylnorapomorphine and pergolide as agonists at striatal dopamine autoreceptors and postsynaptic dopamine receptors. Claustre Y; Fage D; Zivkovic B; Scatton B J Pharmacol Exp Ther; 1985 Feb; 232(2):519-25. PubMed ID: 2857197 [TBL] [Abstract][Full Text] [Related]
4. Different behavioural patterns induced by the dopamine agonist apomorphine analysed by multivariate statistics. Ståhle L; Ungerstedt U Pharmacol Biochem Behav; 1986 Feb; 24(2):291-8. PubMed ID: 3952117 [TBL] [Abstract][Full Text] [Related]
5. On the selectivity and specificity of the antagonism of apomorphine-induced suppression of exploration by sulpiride. Ståhle L; Ungerstedt U Psychopharmacology (Berl); 1989; 99(1):75-9. PubMed ID: 2528780 [TBL] [Abstract][Full Text] [Related]
6. Differential ability of selective and non-selective dopamine agonists to induce climbing in the rat indicates the involvement of both D-1 and D-2 receptors in this behaviour. Davis A; Jenner P; Marsden CD Psychopharmacology (Berl); 1990; 100(1):19-26. PubMed ID: 1967499 [TBL] [Abstract][Full Text] [Related]
7. Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats. Arnt J Eur J Pharmacol; 1985 Jul; 113(1):79-88. PubMed ID: 2931283 [TBL] [Abstract][Full Text] [Related]
8. SKF 38393 and apomorphine modify locomotion and exploration in rats placed on a holeboard by separate actions at dopamine D-1 and D-2 receptors. Fletcher GH; Starr MS Eur J Pharmacol; 1985 Nov; 117(3):381-5. PubMed ID: 3878300 [TBL] [Abstract][Full Text] [Related]
9. Differential agonist profile of the enantiomers of 3-PPP at striatal dopamine autoreceptors: dependence on extracellular dopamine. Clark D; Salah RS; Galloway MP Synapse; 1991 Jul; 8(3):169-76. PubMed ID: 1948667 [TBL] [Abstract][Full Text] [Related]
10. Effects of neuroleptic drugs on the inhibition of exploratory behaviour induced by a low dose of apomorphine: implications for the identity of dopamine receptors. Ståhle L; Ungerstedt U Pharmacol Biochem Behav; 1986 Aug; 25(2):473-80. PubMed ID: 2876441 [TBL] [Abstract][Full Text] [Related]
11. Is inhibition of striatal synaptosomal tyrosine hydroxylation by dopamine agonists a measure of dopamine autoreceptor function? Fowler CJ; Thorell G; Andersson M; Magnusson O Naunyn Schmiedebergs Arch Pharmacol; 1985 Oct; 331(1):12-9. PubMed ID: 2866447 [TBL] [Abstract][Full Text] [Related]
12. Dopamine receptor affinities in vitro and stereotypic activities in vivo of cabergoline in rats. Miyagi M; Itoh F; Taya F; Arai N; Isaji M; Kojima M; Ujiie A Biol Pharm Bull; 1996 Sep; 19(9):1210-3. PubMed ID: 8889042 [TBL] [Abstract][Full Text] [Related]
13. Assessment of dopamine autoreceptor agonist properties of apomorphine, (+)-3-PPP and (-)-3-PPP by recording of yawning behaviour in rats. Ståhle L; Ungerstedt U Eur J Pharmacol; 1984 Feb; 98(2):307-10. PubMed ID: 6714314 [TBL] [Abstract][Full Text] [Related]
14. Effect of the dopamine D-1 antagonist SCH 23390 on rotational behaviour induced by apomorphine and pergolide in 6-hydroxy-dopamine denervated rats. Herrera-Marschitz M; Ungerstedt U Eur J Pharmacol; 1985 Mar; 109(3):349-54. PubMed ID: 3157586 [TBL] [Abstract][Full Text] [Related]
15. Effect of AT II on the exploratory behaviour of rats. Interactions with elymoclavine and bromocryptine. Petkova B; Georgiev V; Kambourova T Acta Physiol Pharmacol Bulg; 1991; 17(2-3):84-90. PubMed ID: 1819920 [TBL] [Abstract][Full Text] [Related]
16. Biphasic effects of dopamine D-2 receptor agonists on sleep and wakefulness in the rat. Monti JM; Hawkins M; Jantos H; D'Angelo L; Fernández M Psychopharmacology (Berl); 1988; 95(3):395-400. PubMed ID: 3137628 [TBL] [Abstract][Full Text] [Related]
17. Autoreceptors mediate the inhibition of dopamine synthesis by bromocriptine and lisuride in rats. Tissari AH; Rossetti ZL; Meloni M; Frau MI; Gessa GL Eur J Pharmacol; 1983 Aug; 91(4):463-8. PubMed ID: 6413231 [TBL] [Abstract][Full Text] [Related]
18. Synergistic effects of D1 and D2 dopamine agonists on turning behaviour in rats. Robertson GS; Robertson HA Brain Res; 1986 Oct; 384(2):387-90. PubMed ID: 2946360 [TBL] [Abstract][Full Text] [Related]
19. Antagonism of bromocriptine-induced cage climbing behaviour in mice by the selective D-2 dopamine receptor antagonists, metoclopramide and molindone. Balsara JJ; Nandal NV; Gada VP; Bapat TR; Chandorkar AG Indian J Physiol Pharmacol; 1986; 30(1):85-90. PubMed ID: 2950056 [TBL] [Abstract][Full Text] [Related]
20. Suppression of exploratory locomotor activity in the rat by the local application of 3-PPP enantiomers into the nucleus accumbens. Svensson L; Ahlenius S Eur J Pharmacol; 1983 Apr; 88(4):393-7. PubMed ID: 6861878 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]